Palantir Needs An Nvidia Moment To Justify Its Valuation
Summary: Palantir’s impressive US revenue growth of 54% in commercial and 40% in government sectors
Summary: Palantir’s impressive US revenue growth of 54% in commercial and 40% in government sectors
Summary: Nvidia’s 1Q25 earnings beat expectations, but investor fatigue led to a muted stock response,
ojos de hojalata/iStock via Getty Images Taking aim at the dangers social media poses for
Summary: Nikola’s stock is in a severe downtrend with no support levels, indicating further weakness
Summary: Devon Energy is undervalued, trading at just 3.5x operating cash flow, with a fair
Summary: Apple has shown significant recovery with strong earnings, beating consensus estimates, and positive iPhone
Summary: Johnson & Johnson offers investors an effective combination of dividend income and dividend growth,
Summary: Growth versus value has long been a key debate in the investing community. And
Summary: The market is more confident on Intel’s earnings than revenues due to headcount reductions
Roland Magnusson/iStock Editorial via Getty Images AstraZeneca’s (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese